|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
03681 SINOMAB BIO-B
Nominal 
1.100 +0.020 (+1.852%) | 2026/06 - Interim RMB(K¥) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |
| Net Cash from / (used in) Operating Activities | -- | (70,478) | (130,801) | (133,847) | (300,538) |
| Net Cash from / (used in) Investing Activities | -- | 16,251 | (94,482) | (96,921) | (81,358) |
| Net Cash from / (used in) Financing Activities | -- | 329,388 | 73,268 | 82,267 | 102,285 |
| Increase / (Decrease) in Cash & Cash Equivalents | -- | 275,161 | (152,015) | (148,501) | (279,611) |
| Cash & Cash Equivalents at beginning of period | -- | 61,900 | 203,664 | 342,887 | 562,983 |
| Effect of Foreign Exchange Rate Changes | -- | (14,353) | 10,251 | 9,278 | 59,515 |
| Others | -- | 0 | 0 | 0 | 0 |
| Cash & Cash Equivalents at end of period | -- | 322,708 | 61,900 | 203,664 | 342,887 |
| Remarks: | Real time quote last updated: 11/09/2026 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB -127,388 |
| %Change | 155.691% |
| EPS / (LPS) | RMB -0.090 |
| NBV Per Share (¥) | RMB 0.261 |